Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Monday, June 17, 2024 | Back issues
Courthouse News Service Courthouse News Service

Snake Oil

The Federal Trade Commission sued Zycal Bioceuticals Healthcare Co., et al., in federal court, for claiming that its Ostinol (Cyplexinol) drug causes osteoporosis patients to grow new bone and cartilage.

BOSTON — The Federal Trade Commission brought a federal complaint against Zycal Bioceuticals Healthcare Co., et al., for claiming that its Ostinol (Cyplexinol) drug causes osteoporosis patients to grow new bone and cartilage.

Categories / Business, Government, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...